20-Hydroxy-eicosatetraenoic acid (20-HETE) is a cytochrome P-450 4A (CYP4A)
metabolite of arachidonic acid (AA) in human and rabbit lung microsomes an
d is a dilator of isolated human pulmonary arteries (PA). However, little i
s known regarding the contribution of P-450 metabolites to pulmonary vascul
ar tone. We examined 1) the effect of two mechanistically distinct omega- a
nd omega 1-hydroxylase inhibitors on perfusion pressures in isolated rabbit
lungs ventilated with normoxic or hypoxic gases, 2) changes in rabbit PA r
ing tone elicited by 20-HETE or omega- and omega 1-hydroxylase inhibitors,
and 3) expression of CYP4A protein in lung tissue. A modest increase in per
fusion pressure (55 +/- 11% above normoxic conditions) was observed in isol
ated perfused lungs during ventilation with hypoxic gas (FIO2 = 0.05). Inhi
bitors of 20-HETE synthesis, 17-oxydecanoic acid (17-ODYA) or N-methylsulfo
nyl-12,12-dibromododec-11-enamide (DDMS), increased baseline perfusion pres
sure above that of vehicle and amplified hypoxia-induced increases in perfu
sion pressures by 92 +/- 11% and 105 +/- 11% over baseline pressures, respe
ctively. 20-HETE relaxed phenylephrine (PE)-constricted PA rings. Treatment
with 17-ODYA enhanced PE-induced contraction of PA rings, consistent with
inhibition of a product that promotes arterial relaxation, whereas 6-(20-pr
opargyloxyphenyl) hexanoic acid (PPOH), an epoxygenase inhibitor, blunted c
ontraction to PE. Conversion of AA into 20-HETE was blocked by 17-ODYA, DDM
S, and hypoxia. CYP4A immunospecific protein confirms expression of CYP4A i
n male rabbit lung tissue. Our data suggest that endogenously produced 20-H
ETE could modify rabbit pulmonary vascular tone, particularly under hypoxic
conditions.